Search filters

List of works by Angeles Alvarez Secord

A Phase I Trial of Dasatinib, an Src-Family Kinase Inhibitor, in Combination with Paclitaxel and Carboplatin in Patients with Advanced or Recurrent Ovarian Cancer ⬇️

scientific article published on July 26, 2012

A Phase II evaluation of weekly topotecan as a single agent second line therapy in persistent or recurrent carcinoma of the cervix: a Gynecologic Oncology Group study

scientific article

A chemoresponse assay for prediction of platinum resistance in primary ovarian cancer

scientific article published on 12 February 2014

A multi-institutional cohort study of adjuvant therapy in stage I-II uterine carcinosarcoma

scientific article

A multi-institutional study of outcomes in stage I-III uterine carcinosarcoma

scientific article published on 05 September 2015

A multicenter evaluation of adjuvant therapy in women with optimally resected stage IIIC endometrial cancer ⬇️

scientific article published on October 17, 2012

A multicenter evaluation of sequential multimodality therapy and clinical outcome for the treatment of advanced endometrial cancer

scientific article

A multicenter, randomized, phase 2 clinical trial to evaluate the efficacy and safety of combination docetaxel and carboplatin and sequential therapy with docetaxel then carboplatin in patients with recurrent platinum‐sensitive ovarian cancer ⬇️

scientific article published on November 9, 2011

A phase II evaluation of elesclomol sodium and weekly paclitaxel in the treatment of recurrent or persistent platinum-resistant ovarian, fallopian tube or primary peritoneal cancer: An NRG oncology/gynecologic oncology group study

article

A phase II evaluation of sunitinib in the treatment of persistent or recurrent clear cell ovarian carcinoma: An NRG Oncology/Gynecologic Oncology Group Study (GOG-254)

A phase II evaluation of weekly gemcitabine and docetaxel for second-line treatment of recurrent carcinosarcoma of the uterus: a gynecologic oncology group study

scientific article

A phase II trial of docetaxel and bevacizumab in recurrent ovarian cancer within 12 months of prior platinum-based chemotherapy ⬇️

scientific article published on April 25, 2013

A phase II trial of oxaliplatin, docetaxel, and bevacizumab as first-line therapy of advanced cancer of the ovary, peritoneum, and fallopian tube

scientific article published on 27 January 2014

A phase II trial of paclitaxel poliglumex in recurrent or persistent ovarian or primary peritoneal cancer (EOC): a Gynecologic Oncology Group Study

scientific article published on 30 September 2008

ASCO Value Framework Highlights the Relative Value of Treatment Options in Ovarian Cancer

scientific article

Adverse events associated with laparoscopy vs laparotomy in the treatment of endometrial cancer

scientific article published on 16 March 2011

An updated clinicopathologic study of early-stage uterine papillary serous carcinoma (UPSC).

scientific article published on 26 August 2009

Analysis of in vitro chemoresponse assays in endometrioid endometrial adenocarcinoma: an observational ancillary analysis

scientific article published on December 2016

Antiangiogenic agents in combination with chemotherapy for the treatment of epithelial ovarian cancer

scientific article published on March 2012

Association between the N-terminally truncated (DeltaN) p63alpha (DeltaNp63alpha) isoform and debulking status, VEGF expression and progression-free survival in previously untreated, advanced stage epithelial ovarian cancer: A Gynecologic Oncology G

scientific article

Associations between lymphovascular space invasion, nodal recurrence, and survival in patients with surgical stage I endometrioid endometrial adenocarcinoma

Attitudes regarding the use of hematopoietic colony-stimulating factors and maintenance of relative dose intensity among gynecologic oncologists

scientific article published in April 2009

Cervical cancer

scientific article published on 01 January 2008

Chemotherapy completion in elderly women with ovarian, primary peritoneal or fallopian tube cancer - An NRG oncology/Gynecologic Oncology Group study

scientific article published on 12 January 2017

Co-expression of angiogenic markers and associations with prognosis in advanced epithelial ovarian cancer: a Gynecologic Oncology Group study

scientific article published on 03 May 2007

Comparison of bevacizumab alone or with chemotherapy in recurrent ovarian cancer patients.

scientific article

Cost Comparison of Genetic Testing Strategies in Women With Epithelial Ovarian Cancer

scientific article published on 3 January 2017

Cost comparison of strategies for the management of venous thromboembolic event risk following laparotomy for ovarian cancer ⬇️

scientific article published on July 12, 2011

Cost effectiveness of alternative strategies for incorporating bevacizumab into the primary treatment of ovarian cancer

scientific article published on 6 August 2013

Cost effectiveness of intraperitoneal compared with intravenous chemotherapy for women with optimally resected stage III ovarian cancer: a Gynecologic Oncology Group study

scientific article

Cost-Effectiveness of BRCA1 and BRCA2 Mutation Testing to Target PARP Inhibitor Use in Platinum-Sensitive Recurrent Ovarian Cancer ⬇️

scientific article published on June 1, 2013

Cost-effectiveness of early palliative care intervention in recurrent platinum-resistant ovarian cancer ⬇️

scientific article published on June 14, 2013

Cost‐effectiveness of combination versus sequential docetaxel and carboplatin for the treatment of platinum‐sensitive, recurrent ovarian cancer ⬇️

scientific article published on May 19, 2011

Dasatinib (BMS-35482) interacts synergistically with docetaxel, gemcitabine, topotecan, and doxorubicin in ovarian cancer cells with high SRC pathway activation and protein expression

scientific article published on February 2014

Dasatinib (BMS-35482) potentiates the activity of gemcitabine and docetaxel in uterine leiomyosarcoma cell lines

scientific article published on 30 September 2014

Disparities in the surgical staging of high-grade endometrial cancer in the United States

scientific article published on 19 January 2017

Does time interval between surgery and intraperitoneal chemotherapy administration in advanced ovarian cancer carry a prognostic impact? An NRG Oncology/Gynecologic Oncology Group study ancillary study

scientific article

Evaluation of in vitro chemoresponse profiles in women with Type I and Type II epithelial ovarian cancers: An observational study ancillary analysis

scientific article published on 30 May 2015

Health-related quality of life outcomes of docetaxel/carboplatin combination therapy vs. sequential therapy with docetaxel then carboplatin in patients with relapsed, platinum-sensitive ovarian cancer: results from a randomized clinical trial

scientific article

High dose rate intraoperative radiotherapy for recurrent cervical cancer and nodal disease ⬇️

scientific article published on 01 October 2003

Independent prognostic relevance of microvessel density in advanced epithelial ovarian cancer and associations between CD31, CD105, p53 status, and angiogenic marker expression: A Gynecologic Oncology Group study

scientific article published on 9 January 2009

Iniparib plus paclitaxel and carboplatin as initial treatment of advanced or recurrent uterine carcinosarcoma: A Gynecologic Oncology Group Study ⬇️

scientific article published on May 24, 2012

Intra-peritoneal cisplatin and whole abdomen hyperthermia for relapsed ovarian carcinoma

scientific article published on 01 March 2006

Lumbee Native American ancestry and the incidence of aggressive histologic subtypes of endometrial cancer

scientific article

MHC Class I–Presented Tumor Antigens Identified in Ovarian Cancer by Immunoproteomic Analysis Are Targets for T-Cell Responses against Breast and Ovarian Cancer ⬇️

scientific article published on February 7, 2011

Maintenance Poly (ADP-ribose) Polymerase Inhibitor Therapy for Ovarian Cancer: Precision Oncology or One Size Fits All?

scientific article published on 26 October 2017

Management of platinum-sensitive recurrent ovarian cancer: a cost-effectiveness analysis

scientific article published on 17 September 2007

Maspin expression in epithelial ovarian cancer and associations with poor prognosis: a Gynecologic Oncology Group study

scientific article

Medical and surgical treatment of placenta percreta to optimize bladder preservation

scientific article published on August 2008

Metformin is associated with improved survival in endometrial cancer

scientific article

Microarray analysis of early stage serous ovarian cancers shows profiles predictive of favorable outcome

scientific article

Minimally Invasive Surgery for Endometrial Cancer: The Horse Is Already out of the Barn ⬇️

scientific article published on January 30, 2012

Minimally invasive surgery versus laparotomy in women with high grade endometrial cancer: A multi-site study performed at high volume cancer centers

scientific article published on 30 April 2012

Multicenter analysis of recurrence and survival in stage IIIA endometrial cancer

scientific article published on 15 May 2009

Multicenter phase II trial of topotecan, cisplatin and bevacizumab for recurrent or persistent cervical cancer

scientific article

Multidisciplinary approach to manage antenatally suspected placenta percreta: updated algorithm and patient outcomes

scientific article published on 22 August 2017

Obesity is associated with worse overall survival in women with low-grade papillary serous epithelial ovarian cancer

scientific article

Obesity: Too big a problem to ignore

scientific article published on April 30, 2012

Outcomes in surgical stage I uterine papillary serous carcinoma

scientific article published on 13 March 2007

Paclitaxel With and Without Pazopanib for Persistent or Recurrent Ovarian Cancer: A Randomized Clinical Trial

scientific article published on 14 December 2017

Pelvic lymph node count is an important prognostic variable for FIGO stage I and II endometrial carcinoma with high-risk histology

scientific article published on 10 January 2006

Performance of sentinel lymph node biopsy in high-risk endometrial cancer

scientific article published on 19 April 2016

Phase II trial of cetuximab and carboplatin in relapsed platinum-sensitive ovarian cancer and evaluation of epidermal growth factor receptor expression: a Gynecologic Oncology Group study

scientific article

Phase III trial of weekly methotrexate or pulsed dactinomycin for low-risk gestational trophoblastic neoplasia: a gynecologic oncology group study

scientific article

Physical strain and urgent need for ergonomic training among gynecologic oncologists who perform minimally invasive surgery ⬇️

scientific article published on May 18, 2012

Predicting 6- and 12-Month Risk of Mortality in Patients With Platinum-Resistant Advanced-Stage Ovarian Cancer: Prognostic Model to Guide Palliative Care Referrals

scientific article published in February 2018

Predictors of reduced relative dose intensity and its relationship to mortality in women receiving multi-agent chemotherapy for epithelial ovarian cancer ⬇️

scientific article published on December 21, 2012

Predictors of severe and febrile neutropenia during primary chemotherapy for ovarian cancer ⬇️

scientific article published on March 15, 2012

Primary surgery versus chemoradiation in the treatment of IB2 cervical carcinoma: a cost effectiveness analysis

scientific article

Prior breast cancer and tamoxifen exposure does not influence outcomes in women with uterine papillary serous carcinoma

scientific article published on 3 January 2017

Profile of pazopanib and its potential in the treatment of epithelial ovarian cancer

scientific article published in 2014

Prospective Evaluation of Lymph Node Processing at Staging Surgery for High-grade Endometrial Cancer

scientific article published on 11 July 2017

Radical hysterectomy and pelvic lymphadenectomy for stage IB2 cervical cancer

scientific article published on May 2004

Randomized phase III trial of gemcitabine compared with pegylated liposomal doxorubicin in patients with platinum-resistant ovarian cancer

scientific article

Rectus abdominis myocutaneous and myoperitoneal flaps for neovaginal reconstruction after radical pelvic surgery: comparison of flap-related morbidity

scientific article

Relationship between minimally invasive hysterectomy, pelvic cytology, and lymph vascular space invasion: a single institution study of 458 patients

scientific article published on 28 February 2014

Relationship between tamoxifen use and high risk endometrial cancer histologic types

scientific article published on 19 October 2008

Resection of lymph node metastases influences survival in stage IIIC endometrial cancer

scientific article published on 29 August 2005

Retrospective Analysis of Selective Lymphadenectomy in Apparent Early-Stage Endometrial Cancer

scientific article published on 28 February 2005

Retrospective review of an intraoperative algorithm to predict lymph node metastasis in low-grade endometrial adenocarcinoma ⬇️

scientific article published on July 13, 2011

Robotic-assisted laparoscopic gynecologic procedures in a fellowship training program

scientific article

SGO guidance document for clinical trial designs in ovarian cancer: a changing paradigm

scientific article

Safety and feasibility of contained uterine morcellation in women undergoing laparoscopic hysterectomy

Severe ulceration over mandibular torus in an ovarian cancer patient receiving bevacizumab therapy

scientific article published on 14 September 2011

Stage I, grade 3 endometrioid adenocarcinoma of the endometrium: an analysis of clinical outcomes and patterns of recurrence

scientific article published on 28 October 2009

Stage II uterine papillary serous carcinoma: Carboplatin/paclitaxel chemotherapy improves recurrence and survival outcomes

scientific article published on 01 January 2009

Surgical staging for endometrial cancer in the elderly — Is there a role for lymphadenectomy? ⬇️

scientific article published on May 12, 2012

Synuclein-γ in uterine serous carcinoma impacts survival: An NRG Oncology/Gynecologic Oncology Group study

scientific article published on 7 December 2016

TP53 Status is Associated with Thrombospondin1 Expression In vitro

scientific article published on 29 October 2013

The complex triad of obesity, diabetes and race in Type I and II endometrial cancers: prevalence and prognostic significance

scientific article published in April 2014

The influence of radiation modality and lymph node dissection on survival in early-stage endometrial cancer

scientific article published on 02 June 2011

The prognostic significance of positive peritoneal cytology and adnexal/serosal metastasis in stage IIIA endometrial cancer

scientific article published on 02 October 2006

The relationship between serum vascular endothelial growth factor, persistent disease, and survival at second-look laparotomy in ovarian cancer

scientific article published on 01 July 2004

The role of PET scanning in the detection of recurrent cervical cancer

scientific article

The role of lymphadenectomy in the management of preoperative grade 1 endometrial carcinoma

scientific article published on 13 January 2009

The role of multi-modality adjuvant chemotherapy and radiation in women with advanced stage endometrial cancer

scientific article published on 6 August 2007

The role of optimal debulking in advanced stage serous carcinoma of the uterus

scientific article published in July 2004

The search for biomarkers to direct antiangiogenic treatment in epithelial ovarian cancer

scientific article published on 30 August 2014

Tumor grade and chemotherapy response in endometrioid endometrial cancer

scientific article published on 27 April 2016

Urinary diversion in the genitourinary cancer survivor

scientific article

Vaginal cuff thermal injury by mode of colpotomy at total laparoscopic hysterectomy: a randomized clinical trial

scientific article published on 8 October 2014

Paulina is supported by:

About Paulina

Help